Do nicotine pouches cause gum recession?

Last updated 1 October 2026

Short answer

Gum recession has been documented in nicotine pouch users, but only in a handful of individual clinical case reports, not in a study large enough to say how common it is. The reported pattern is localized: recession appears specifically where the pouch is habitually placed, not across the whole mouth. This page summarizes the direct pouch evidence, the plausible mechanism, and what the comparable evidence from tobacco-containing snus does and does not add. For the wider picture on nicotine pouches and oral health, see the oral health overview.

What the case reports found

The clearest evidence comes from two clinical case reports published in BMC Oral Health in 2025. Both involved young, otherwise healthy men with no other apparent risk factors:

A 22-year-old who used pouches daily for 11 months, placing them at the maxillary canine sites, developed isolated gum recession and a whitish leukoplakia patch at that exact location.
A 25-year-old who used pouches daily for 18 months, mainly in the upper premolar-to-canine region, developed localized recession on the cheek-facing (buccal) side of the gum in that same area, with no recession found elsewhere.

In both cases the clinicians carried out periodontal charting, radiographs, and a mucosal exam, and ruled out generalized gum disease, teeth grinding, and aggressive tooth-brushing as alternative causes. The author concludes the pattern points to a site-specific chemical and/or mechanical irritation from the pouch itself, though a biopsy to confirm the tissue changes was recommended in one case and declined by the patient (Alkhatib, 2025).

Two case reports describe two people. They are useful for showing that this can happen and for describing what it looks like. They cannot establish how frequently it happens, whether certain placement habits or pouch strengths raise the risk, or whether it happens to a meaningful share of long-term users.

What the broader mucosal research adds

A separate 2024 case series in Diagnostic Pathology biopsied five daily pouch users at their placement sites and found consistent tissue changes (thickening, swelling, dilated capillaries, mild chronic inflammation) but it screened out anyone with signs of active periodontal disease before enrolling, so it was not designed to detect recession and does not report on it (Miluna-Meldere et al., 2024).

A 2025 pilot study followed 23 dentists who switched exclusively to one pouch brand, with a barrier layer marketed to reduce mucosal irritation, for five weeks. Self-reported mucosal lesions and gingival irritation both fell substantially. Gum recession, where already present, stayed exactly the same, 39.1% before the switch and 39.1% after, though this figure is self-reported (La Rosa, Fagerström et al., 2025). That fits with recession being a structural loss rather than an active, reversible inflammation: changing formulation reduced irritation but did not restore tissue already lost. The manufacturer donated the product, and the authors received no funding beyond university publication fees. Several authors disclosed industry ties, including consulting and grants. With 23 participants and self-reported outcomes, read the specific percentages cautiously.

Two small comparative studies from 2026 add to this. A cross-sectional study of 26 male firefighters, 12 pouch users and 14 non-users, found worse periodontal status in users, with more sites showing attachment loss of 3 mm or more (P=0.009). Recession was more common in users, 66.7% against 35.7% of participants, but that difference was not statistically significant, and results were not adjusted for oral hygiene or past tobacco use (Chaffee et al., 2026). A cross-sectional study of 272 people aged 18 to 30 compared 126 pouch users, 63 users of tobacco-derived pouches and 83 non-users. It examined gingival recession among other signs and reported no increased periodontal disease for up to six years of use, but its abstract gives no recession-specific result (Daneshian et al., 2026).

Why recession might occur here: two possible mechanisms

Nothing in the pouch-specific literature isolates a single cause, but two mechanisms are biologically plausible and appear in the broader nicotine and periodontal literature:

Mechanical. A pouch is a small fibrous sachet held against the gum for extended periods, day after day, usually in roughly the same spot. Sustained direct pressure and friction against thin gum tissue is a recognized way recession can develop generally, independent of any drug effect.

Chemical/biological. Nicotine has measurable effects on the cells that maintain gum tissue. A 2010 review of nicotine and periodontal tissue found nicotine alters gum fibroblast attachment, reduces collagen production while increasing the enzyme that breaks it down, and impairs immune cells needed for tissue turnover. These effects were drawn mostly from smoking research but attributed to nicotine rather than smoke (Malhotra et al., 2010). A 2024 review of nicotine patches, a non-oral, non-combustion source, found broadly similar fibroblast and blood-flow effects, though markedly milder than smoking's (Alayadi, 2024). Neither review examined pouches directly; both establish that nicotine is not inert to gum tissue, consistent with, but not proof of, a role in the case-report recession.

What the tobacco-containing comparison shows, and why it doesn't transfer directly

Tobacco-containing smokeless products, unlike nicotine pouches, have a larger evidence base. A 2025 narrative review reports that smokeless tobacco users generally, not snus alone, have roughly 1.7 times the odds of gum recession, a figure from six studies, all from Asian countries; the review also calls localized recession near where the product is held a well-known side effect of these products, and says recession tends to be more prominent at the front teeth, which is the pattern reported for pouches (Bogdanska et al., 2025). That pattern match is worth noting, but it is smokeless-tobacco evidence, not pouch evidence: these products deliver tobacco-leaf compounds pouches do not contain, so the same rate cannot be assumed to carry over. In one 60-person study with no control group, users who switched from snus to a nicotine pouch saw reversible mucosal changes normalize. That is consistent with a tobacco-leaf contribution but does not show that tobacco leaf, rather than nicotine, drives the lesions (Scherer, Pluym & Scherer, 2024); whether it holds for recession has not been tested.

What is not known

No published study has measured gum recession rates across a representative sample of nicotine pouch users or tracked recession over months or years of use. The two comparative studies above are small cross-sectional studies, which cannot show cause, and neither reports a statistically significant recession difference. A 2024 critical review of the oral nicotine pouch literature found only two studies of oral nicotine pouches in total and stated there is not enough data to draw conclusions about periodontal outcomes specific to these products (Scherer, Pluym & Scherer, 2024). Whether recession is common, rare, dose-dependent on pouch strength or placement duration, or specific to certain users is not established. For the related question of whether pouches can cause gum disease more broadly, see the gum disease cluster; for the full picture, see the oral health overview.

Evidence reviewed 2026-08-19.